Form 4: GeneDx Holdings Corp. Executive Sells Shares to Cover Tax Obligations
SEC Filing Form 4
Kareem Saad, Chief Transformation Officer of GeneDx Holdings Corp., sold 897 shares of Class A Common Stock to cover tax withholding obligations related to the vesting and settlement of restricted stock units.
Summary
- On March 12, 2024, Kareem Saad, the Chief Transformation Officer of GeneDx Holdings Corp., sold 897 shares of Class A Common Stock.
- The shares were sold at a weighted average price of $9.2095.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Following the transaction, Saad directly owns 26,411 shares of GeneDx Holdings Corp.
- The shares were sold in multiple transactions at prices ranging from $9.00 to $9.21, inclusive.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of the company's financial health or future prospects.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of the stock sale transaction. |
| 03/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.